CTOs on the Move

Kindred Hospital - Denver

www.kh-denver.com

 
Kindred Hospital - Denver is a Denver, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

BioCentury Publications

BioCentury Publications, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. BioCentury Publications, Inc. is based in Redwood City, CA. You can find more information on BioCentury Publications, Inc. at www.biocentury.com

CreoDent Prosthetics

CreoDent Prosthetics is a nationally recognized premier full service dental laboratory and a milling center located in New York. With 2 facilities in NYC and Newburgh, NY, CreoDent specialize in both implant and esthetic dentistry. CreoDent continues to grow and develop new products and services to our clients nationwide. Our products and services have given CreoDent its reputation as the finest dental laboratory to work with.

Zwanger Pesiri Radiology Group

Zwanger Pesiri Radiology Group is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Lindenhurst, NY. To find more information about Zwanger Pesiri Radiology Group, please visit www.zwangerpesiri.com

Diabetes Centers of America

Diabetes Centers of America is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

RaNA Therapeutics

RaNA Therapeutics is pioneering the discovery of a new class of RNA-targeted medicines that selectively activate protein expression within the body`s own cells. By targeting specific genes, RaNA`s novel drugs work epigenetically to precisely upregulate the expression of beneficial proteins in order to treat or prevent disease. The company`s leadership leverages preeminent founders and advisors in the field, and the strength of its fundamental patents, technology, and know-how that underlie the discovery and development of therapeutics that selectively activate RNA. RaNA is applying its proprietary technology to rapidly advance a pipeline of novel drugs for diverse therapeutic areas, with an initial emphasis in the fields of rare genetic disorders, inflammation, oncology, metabolic diseases and neurodegenerative diseases.